NZ589034A - Detecting genetic predisposition to osteoarthritis associated conditions - Google Patents
Detecting genetic predisposition to osteoarthritis associated conditionsInfo
- Publication number
- NZ589034A NZ589034A NZ589034A NZ58903409A NZ589034A NZ 589034 A NZ589034 A NZ 589034A NZ 589034 A NZ589034 A NZ 589034A NZ 58903409 A NZ58903409 A NZ 58903409A NZ 589034 A NZ589034 A NZ 589034A
- Authority
- NZ
- New Zealand
- Prior art keywords
- subject
- osteoarthritis
- associated conditions
- genetic predisposition
- detecting genetic
- Prior art date
Links
- 201000008482 osteoarthritis Diseases 0.000 title abstract 3
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 title 1
- 206010061818 Disease progression Diseases 0.000 abstract 2
- 230000005750 disease progression Effects 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4999208P | 2008-05-02 | 2008-05-02 | |
| US11874408P | 2008-12-01 | 2008-12-01 | |
| PCT/US2009/042746 WO2009135218A2 (en) | 2008-05-02 | 2009-05-04 | Detecting genetic predisposition to osteoarthritis associated conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ589034A true NZ589034A (en) | 2012-10-26 |
Family
ID=41210581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ589034A NZ589034A (en) | 2008-05-02 | 2009-05-04 | Detecting genetic predisposition to osteoarthritis associated conditions |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20100098775A1 (enExample) |
| EP (3) | EP3467126A1 (enExample) |
| JP (3) | JP5762282B2 (enExample) |
| AU (1) | AU2009242490B2 (enExample) |
| CA (1) | CA2723239C (enExample) |
| DK (2) | DK2283156T3 (enExample) |
| ES (2) | ES2708826T3 (enExample) |
| NZ (1) | NZ589034A (enExample) |
| WO (1) | WO2009135218A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2708826T3 (es) * | 2008-05-02 | 2019-04-11 | Orig3N Inc | Detección de la predisposición genética a afecciones asociadas a la osteoartritis |
| US20120115137A1 (en) * | 2010-08-31 | 2012-05-10 | Kornman Kenneth S | Methods of Predicting Osteoarthritis |
| US10221456B2 (en) * | 2012-08-06 | 2019-03-05 | Merck Patent Gmbh | Genetic markers for predicting responsiveness to FPG-18 compound |
| CN104755629A (zh) * | 2012-08-06 | 2015-07-01 | 默克专利有限公司 | 软骨疾病的预后生物标记 |
| CA3011363A1 (en) | 2016-01-12 | 2017-07-20 | Interleukin Genetics, Inc. | Methods for predicting response to treatment |
| US10329620B2 (en) | 2017-01-12 | 2019-06-25 | Cardioforecast Ltd. | Methods and kits for treating cardiovascular disease |
| HUE058848T2 (hu) | 2017-09-29 | 2022-09-28 | Merck Patent Gmbh | FGF-18 vegyületre vonatkozó válaszkészség elõrejelzésére szolgáló gyulladásos biomarkerek |
| SI3687558T1 (sl) | 2017-09-29 | 2022-08-31 | Merck Patent Gmbh | Presnovni biooznačevalci za napovedovanje odzivnosti na spojino FGF-18 |
| EP3850113B1 (en) * | 2018-09-10 | 2024-04-03 | Merck Patent GmbH | Markers useful in enrichment strategies for the treatment of osteoarthritis |
| US12370240B2 (en) | 2018-11-28 | 2025-07-29 | Genascence Corporation | Methods and compositions for treating osteoarthritis |
| CA3142662A1 (en) | 2019-06-06 | 2020-12-10 | Sitokine Limited | Compositions and methods for treating lung, colorectal and breast cancer |
| US20220265773A1 (en) * | 2019-08-02 | 2022-08-25 | New York University | Methods and compositions for treating arthritis |
| WO2021028469A1 (en) | 2019-08-12 | 2021-02-18 | Sitokine Limited | Compositions and methods for treating cytokine release syndrome and neurotoxicity |
| WO2021205013A1 (en) | 2020-04-09 | 2021-10-14 | Sitokine Limited | Compositions and methods for treating covid-19 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8311018D0 (en) | 1983-04-22 | 1983-05-25 | Amersham Int Plc | Detecting mutations in dna |
| US4998617A (en) * | 1986-09-15 | 1991-03-12 | Laura Lupton Inc | Facial cosmetic liquid make up kit |
| US4968607A (en) * | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
| US5459039A (en) | 1989-05-12 | 1995-10-17 | Duke University | Methods for mapping genetic mutations |
| FR2650840B1 (fr) | 1989-08-11 | 1991-11-29 | Bertin & Cie | Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications |
| US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
| DE69433811T2 (de) | 1993-01-07 | 2005-06-23 | Sequenom, Inc., San Diego | Dns - sequenzierung durch massenspektronomie |
| US5593826A (en) | 1993-03-22 | 1997-01-14 | Perkin-Elmer Corporation, Applied Biosystems, Inc. | Enzymatic ligation of 3'amino-substituted oligonucleotides |
| US5686246A (en) * | 1995-08-03 | 1997-11-11 | Kornman; Kenneth S. | Detecting genetic predisposition to periodontal disease |
| US5942390A (en) | 1996-01-12 | 1999-08-24 | Cedars-Sinai Medical Center | Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism |
| US5698399A (en) * | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
| GB9621129D0 (en) * | 1996-10-10 | 1996-11-27 | Duff Gordon W | Detecting genetic predisposition to sight-threatening diabetic retinopathy |
| GB9706359D0 (en) * | 1997-03-27 | 1997-05-14 | Gemini International Holdings | Polymorphisms of an il-1 receptor antagonist gene |
| GB9711040D0 (en) * | 1997-05-29 | 1997-07-23 | Duff Gordon W | Prediction of inflammatory disease |
| WO2003064600A2 (en) * | 2002-01-25 | 2003-08-07 | Interleukin Genetics, Inc. | The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| EP2186913B1 (en) * | 2003-11-26 | 2016-02-10 | Celera Corporation | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
| CA2631675A1 (en) * | 2005-11-30 | 2007-06-21 | The University Of North Carolina At Chapel Hill | Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same |
| ES2708826T3 (es) * | 2008-05-02 | 2019-04-11 | Orig3N Inc | Detección de la predisposición genética a afecciones asociadas a la osteoartritis |
| US9037472B2 (en) | 2012-04-20 | 2015-05-19 | Nuance Communications, Inc. | Method and system for facilitating communications for a user transaction |
-
2009
- 2009-05-04 ES ES15193948T patent/ES2708826T3/es active Active
- 2009-05-04 EP EP18202413.3A patent/EP3467126A1/en not_active Withdrawn
- 2009-05-04 EP EP15193948.5A patent/EP3059323B1/en not_active Not-in-force
- 2009-05-04 AU AU2009242490A patent/AU2009242490B2/en not_active Ceased
- 2009-05-04 US US12/435,260 patent/US20100098775A1/en not_active Abandoned
- 2009-05-04 JP JP2011507714A patent/JP5762282B2/ja active Active
- 2009-05-04 WO PCT/US2009/042746 patent/WO2009135218A2/en not_active Ceased
- 2009-05-04 DK DK09740020.4T patent/DK2283156T3/en active
- 2009-05-04 CA CA2723239A patent/CA2723239C/en active Active
- 2009-05-04 DK DK15193948.5T patent/DK3059323T3/en active
- 2009-05-04 EP EP09740020.4A patent/EP2283156B1/en not_active Not-in-force
- 2009-05-04 NZ NZ589034A patent/NZ589034A/xx not_active IP Right Cessation
- 2009-05-04 ES ES09740020.4T patent/ES2561316T3/es active Active
-
2015
- 2015-06-09 JP JP2015116397A patent/JP6263499B2/ja active Active
-
2016
- 2016-08-10 US US15/233,122 patent/US20160340734A1/en not_active Abandoned
-
2017
- 2017-12-18 JP JP2017241315A patent/JP2018038436A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009242490A1 (en) | 2009-11-05 |
| EP2283156A2 (en) | 2011-02-16 |
| US20160340734A1 (en) | 2016-11-24 |
| JP2011520433A (ja) | 2011-07-21 |
| JP2018038436A (ja) | 2018-03-15 |
| JP5762282B2 (ja) | 2015-08-12 |
| ES2708826T3 (es) | 2019-04-11 |
| AU2009242490B2 (en) | 2015-01-22 |
| US20100098775A1 (en) | 2010-04-22 |
| EP3467126A1 (en) | 2019-04-10 |
| WO2009135218A3 (en) | 2010-04-01 |
| JP6263499B2 (ja) | 2018-01-17 |
| CA2723239C (en) | 2020-07-21 |
| EP3059323B1 (en) | 2018-12-12 |
| CA2723239A1 (en) | 2009-11-05 |
| DK3059323T3 (en) | 2019-03-04 |
| EP2283156B1 (en) | 2015-11-11 |
| EP3059323A1 (en) | 2016-08-24 |
| JP2015211677A (ja) | 2015-11-26 |
| ES2561316T3 (es) | 2016-02-25 |
| WO2009135218A2 (en) | 2009-11-05 |
| DK2283156T3 (en) | 2016-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ589034A (en) | Detecting genetic predisposition to osteoarthritis associated conditions | |
| WO2009073345A3 (en) | Assay for detecting genetic abnormalities in genomic nucleic acids | |
| WO2012112970A3 (en) | Methods and compositions for detecting genetic material | |
| NZ589863A (en) | Genetic markers for weight management and methods of use thereof | |
| NZ599110A (en) | Genetic polymorphisms in age-related macular degeneration | |
| WO2012079010A3 (en) | Improved method and kit for determining severity and progression of periodontal disease | |
| AU2009355009A8 (en) | THD primer target detection | |
| WO2008147930A3 (en) | Methods and kits for linking polymorphic sequences to expanded repeat mutations | |
| WO2011153354A8 (en) | Methods and kits for in situ detection of nucleotide sequences | |
| EP1988178A3 (en) | Nucleotide primer set and nucleotide probe for detecting genotype of serum amyloid A1(SAA1) | |
| NZ591711A (en) | A method for predicting athletic performance potential | |
| AU2010202926B2 (en) | Markers and methods relating to the assessment of Alzheimer's disease | |
| EP2708607A3 (en) | Genetic markers for Myb28 | |
| EP1975249A3 (en) | Nucleotide primer set and nucleotide probe for detecting genotype of N-acetyltransferase 2 (NAT2) | |
| NZ602551A (en) | Genetic marker for the diagnosis of dementia with lewy bodies | |
| WO2010099378A3 (en) | Assay for detection of human parvovirus nucleic acid | |
| WO2013052587A3 (en) | Methods for identifying and treating an individual with an inflammatory disease using fatty acid-based therapies | |
| CN103952481B (zh) | 用于检测等位基因cyp2c19*3的引物组合及检测试剂盒 | |
| WO2009063843A1 (ja) | ヒト体脂肪量と関連する遺伝子多型に基づく肥満発症リスクの判定方法 | |
| Cheon et al. | Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases | |
| WO2012024189A3 (en) | Compositions and methods for determining predisposition to developing metabolic syndrome | |
| WO2009057640A1 (ja) | Brca1 関連タンパク質（ｂｒａｐ）遺伝子内一塩基多型を用いた炎症性疾患の判定方法 | |
| RU2014107505A (ru) | Генетический маркер для диагностики деменции с тельцами леви | |
| CN103409541B (zh) | 一种试剂盒在检测多种生物pcr反应假阴性中的用途 | |
| WO2009140191A3 (en) | Detection of disease related gene mutations by single molecule amplification with multiplex ligation assays |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 04 MAY 2016 BY CULLENS Effective date: 20130430 |
|
| S23 | Proceedings under section 23: mention of inventor as such in patent |
Free format text: INVENTOR ABRAMSON, STEVEN B., ATTUR, MUKUNDAN ADDED Effective date: 20150115 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 MAY 2017 BY COMPUTER PACKAGES INC Effective date: 20160419 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 MAY 2018 BY COMPUTER PACKAGES INC Effective date: 20170518 |
|
| ASS | Change of ownership |
Owner name: ORIG3N, INC., US Effective date: 20180501 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 MAY 2019 BY COMPUTER PACKAGES INC Effective date: 20180501 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 MAY 2020 BY COMPUTER PACKAGES INC Effective date: 20190501 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 MAY 2021 BY SPRUSON + FERGUSON PTY LTD Effective date: 20200430 |
|
| LAPS | Patent lapsed |